Diana Al-Sarayfi

Search results

• 2022

  R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

  Al-Sarayfi, D., Meeuwes, F. O., Durmaz, M., Issa, D. E., Brouwer, R. E., Beeker, A., van Rhenen, A., Mutsaers, P. G. N. J., Bohmer, L. H., van der Poel, M. W. M., te Boome, L., van Meerten, T., Chamuleau, M. E. D., Zijlstra, J. M., Brink, M. & Nijland, M., 2-Sept-2022, In: Blood cancer journal. 12, 9, 4 p., 125.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

  File
  2 Citations (Scopus)

  193 Downloads (Pure)